6 articles
WISE S.p.A., an Italian implantable-electrode company working in neuromonitoring, neuromodulation and BCI, closed an oversubscribed €30 million ($34.8M) Series D on 17 June 2026. The lead application is the company's Heron percutaneous spinal cord stimulation lead.
At least nine significant funding rounds in Q1 2026 brought total BCI investment past $960 million, with capital spreading across invasive, endovascular, ultrasound, and neurostimulation modalities.
Sam Altman's brain-computer interface startup raised the second-largest BCI round in history. The scientific community is asking whether the physics adds up.
The invasive-BCI startup has now raised over $160 million in a year, with Alibaba and Tencent both on the cap table and multicenter clinical trials planned for later this year.
The two-month-old startup founded by Shanda billionaire Tianqiao Chen and former NeuroXess founder Phoenix Peng secures the largest early-stage BCI funding in China, betting that focused ultrasound can reach deeper brain circuits than any implant.
Science Corporation closes a $230 million Series C led by Khosla Ventures and Lightspeed, pushing its valuation past $1 billion as it targets European launch of the PRIMA vision-restoration implant by mid-2026.
Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.
No spam. One-click unsubscribe. We respect your privacy.